Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
SAKAR HEALTHCARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 21.1713.2110.299.214.22

What is the latest EV/Core EBITDA ratio of SAKAR HEALTHCARE ?

The latest EV/Core EBITDA ratio of SAKAR HEALTHCARE is 21.17 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202421.17
Mar202313.21
Mar202210.29
Mar20219.21
Mar20204.22

How is EV/Core EBITDA of SAKAR HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2024 21.17
60.26
Mar2023 13.21
28.38
Mar2022 10.29
11.73
Mar2021 9.21
118.25
Mar2020 4.22 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare EV/Core EBITDA ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹694.9 Cr 0.2% 4.1% 4.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,068.0 Cr 1.4% 0.1% 13.9% Stock Analytics
DIVIS LABORATORIES ₹177,105.0 Cr 0.8% 12.3% 47.2% Stock Analytics
CIPLA ₹122,016.0 Cr 2.6% -0.1% 0.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,651.0 Cr 7.8% 12.9% 13.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,942.0 Cr 2.7% -0.6% 14.4% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

0.2%

4.1%

4.5%

SENSEX

2.1%

3.7%

14.3%


You may also like the below Video Courses